Medical Director - Women's Health (Phase III)

Location: UK or EU (hybrid / remote considered)

Contract: Permanent, full-time

Reporting to: Chief Medical Officer

The Opportunity

We are partnering with a clinical-stage organisation advancing a late-phase programme in women's health, with a specific focus on neonatal and maternal indications.

This is a Medical Director appointment with genuine scope. You will own the medical strategy behind a Phase III programme, act as the internal and external medical authority for the asset, and work directly with executive leadership as the programme moves toward registration.

It is a rare combination: a therapeutic area with real unmet need, an asset in late-stage development, and a role with the seniority to shape how it gets there.

What You'll Do

- Provide medical leadership across the Phase III programme — protocol design, endpoint strategy, and clinical development plan
- Act as the medical expert for the asset internally and with external stakeholders including investigators, sites, KOLs, ethics committees and regulators
- Oversee medical monitoring, safety review and benefit–risk assessment throughout the trial lifecycle
- Provide clinical input into regulatory submissions and interactions with the MHRA, EMA and other agencies
- Partner with Clinical Operations, Biostatistics, Regulatory,



Pharmacovigilance and Programme Management to keep delivery on track
- Build and maintain KOL and investigator relationships across the women's health community
- Contribute to publications, advisory boards, scientific communications and congress activity
- Support due diligence, medical input to business development, and evidence generation strategy as required

What We're Looking For

- MD, MBBS or equivalent medical qualification, with a licence to practise
- Demonstrable experience as a Medical Director (or equivalent senior medical role) within biotech, pharma or a CRO
- Direct experience of Phase III clinical development — protocol authorship, medical monitoring and late-phase delivery
- Therapeutic expertise in women's health; neonatal, maternal–fetal or obstetric experience is a significant advantage
- Working knowledge of ICH-GCP and the EU/UK regulatory environment
- Based in, and eligible to work in, the UK or EU
- Specialist clinical background in obstetrics, gynaecology, neonatology or maternal–fetal medicine
- Prior involvement in a regulatory submission or approval
- Experience in a small or scaling company where the remit extends beyond a single programme
- Publication record and standing within the therapeutic community

#J-18808-Ljbffr

📌 Medical Director (España)
🏢 Green Life Science
📍 España